Procter & Gamble Health Limited

Equities

PGHL

INE199A01012

Pharmaceuticals

Market Closed - Bombay S.E. 06:00:50 2024-04-19 am EDT 5-day change 1st Jan Change
4,698 INR +0.10% Intraday chart for Procter & Gamble Health Limited -2.09% -5.03%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Procter & Gamble Health Limited Declares Interim Dividend for the Financial Year 2023-24, Payable on or Before March 3, 2024 CI
Procter & Gamble Health Limited Declares Special Dividend for the Financial Year 2023-24, Payable on or Before March 3, 2024 CI
Procter & Gamble Health Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 CI
Procter & Gamble Health Limited Reports Earnings Results for the First Quarter Ended September 30, 2023 CI
Procter & Gamble Hygiene to Discontinue Injection Production at Goa, Unit, India MT
Procter & Gamble Health Limited Discontinues Production of Injections at its Manufacturing Plant in Goa Effective September 30, 2023 CI
Procter & Gamble Health's Net Profit Slumps in Fiscal Q4; Shares Dip 5% MT
Procter & Gamble Health Limited Reports Earnings Results for the Full Year Ended June 30, 2023 CI
Procter & Gamble Health Limited Reports Earnings Results for the Fourth Quarter Ended June 30, 2023 CI
Procter & Gamble Health Limited Recommends Final Dividend,Payable Between November 28, 2023 to December 18, 2023 CI
Procter & Gamble Health Limited Announces Change in Senior Management Personnel CI
Procter & Gamble India to invest $244 million to set up manufacturing facility RE
Procter & Gamble Health Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023 CI
Procter & Gamble Health Appoints CFO MT
Procter & Gamble Health Limited Appoints Lokesh Chandak as Chief Financial Officer, Effective April 1, 2023 CI
Procter & Gamble Health's CFO Resigns MT
Procter & Gamble Health Limited Announces Board Changes CI
Procter & Gamble Health Limited Announces Resignation of Amit Gupta as Executive Director, Effective March 31, 2023 CI
Procter & Gamble Health Limited Announces Resignation of Amit Gupta as Chief Financial Officer, Effective March 31, 2023 CI
Procter & Gamble Health Limited Recommends an Interim Dividend for the Financial Year 2022-23, Payable on or Before March 05, 2023 CI
Procter & Gamble Health Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022 CI
Procter & Gamble Health Limited Reports Earnings Results for the First Quarter Ended September 30, 2022 CI
Procter & Gamble Health Limited Announces Intimation of Shifting of the Registered Office CI
Procter & Gamble Health Limited Reports Earnings Results for the Full Year Ended June 30, 2022 CI
Procter & Gamble Health's Fiscal Q4 Profit Climbs to $5 Million MT
Chart Procter & Gamble Health Limited
More charts
Procter & Gamble Health Limited is an India-based company that is primarily engaged in the manufacturing of pharmaceutical products. The Company is engaged in the manufacturing and marketing of over-the-counter products, vitamins, minerals, and supplements products for a healthy lifestyle. The Company’s brands include Cosome, Evion, Neurobion, Seven Seas, Nasivion, Polybion, and Livogen. Cosome is a medicine which is used to help relieve dry coughs and related congestion symptoms. Evion is a Vitamin E capsules. The Evion range has different variants with different levels of Vitamin E, such as Evion 400, Evion 200, and Evion 600. Neurobion offers a range of neurotropic B-Vitamins which are a combination to help treat nerve damage and regenerate the nerves to relieve symptoms. Nasivion Classic Nasal Spray starts working on a blocked nose in 25 seconds. Polybion is a brand that helps with release and hence supports an active life.
More about the company

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. PGHL Stock
  4. News Procter & Gamble Health Limited
  5. Procter & Gamble Health : Net Profit Plunges in Fiscal Q3